Y Intercept Hong Kong Ltd Purchases Shares of 3,863 iShares Biotechnology ETF (NASDAQ:IBB)

Y Intercept Hong Kong Ltd purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 3,863 shares of the financial services provider’s stock, valued at approximately $511,000.

Other institutional investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth about $29,000. HHM Wealth Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the period. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth about $36,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.1 %

NASDAQ:IBB opened at $137.03 on Friday. The company has a 50-day moving average price of $135.91 and a 200-day moving average price of $140.62. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The stock has a market cap of $6.33 billion, a price-to-earnings ratio of 24.52 and a beta of 0.77.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.